{"version":"1.0","type":"link","title":"Incidence of endocrine toxicities in patients with solid tumor malignancies receiving curative-intent immune checkpoint inhibitor (ICI) therapy: A single institution experience.","author_name":"Kurz H 외","author_url":"https://prs-insight.online/author/Kurz%20H","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/96827","thumbnail_width":1200,"thumbnail_height":630}